Oncopeptides AB (publ) (LON:0RN4)
London · Delayed Price · Currency is GBP · Price in SEK 4.898
-0.223 (-4.35%)
At close: Sep 15, 2025
Oncopeptides AB Employees
Oncopeptides AB had 80 employees as of December 31, 2024. The number of employees increased by 23 or 40.35% compared to the previous year.
Employees
80
Change (1Y)
23
Growth (1Y)
40.35%
Revenue / Employee
52.06K GBP
Profits / Employee
-273.43K GBP
Market Cap
85.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80 | 23 | 40.35% |
| Dec 31, 2023 | 57 | 16 | 39.02% |
| Dec 31, 2022 | 41 | -121 | -74.69% |
| Dec 31, 2021 | 162 | -118 | -42.14% |
| Dec 31, 2020 | 280 | 192 | 218.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| HSBC Holdings | 211,304 |
| Shell | 96,000 |
| Unilever | 115,964 |
| Rolls-Royce Holdings | 42,400 |
| British American Tobacco p.l.c. | 48,989 |
| Rio Tinto Group | 60,000 |
| BP p.l.c. | 100,500 |